ROS Therapeutics ApS

CVR 39507501 · Private limited company (ApS) · In voluntary liquidation

ROS Therapeutics ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry fremstilling af farmaceutiske præparater. The company is no longer active (status: in voluntary liquidation). 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -8.0m and a net result of DKK -1.2m.

Company details

CVR number
39507501
Status
In voluntary liquidation
Company type
Private limited company (ApS)
Founded
Address
c/o Hanne Damgaard Jensen, Veddelev Engvej 6
4000 Roskilde
Municipality
Roskilde
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 148k
Employees
1 (2018)
Auditor
BDO Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 8
Missing annual reportNo
Negative equityYes
Equity ratio-1,320.4%
Current ratio199%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -544kDKK -584k
Net profitDKK -1.2mDKK -1.3m
EquityDKK -8.0mDKK -6.6m
Total assetsDKK 602kDKK 1.3m
CashDKK 580k–
Short-term debtDKK 303k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring om udvidet gennemgang · BDO Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025182
1 Jan 2024 – 31 Dec 2024181
1 Jan 2023 – 31 Dec 2023155
1 Jan 2022 – 31 Dec 2022180
1 Jan 2021 – 31 Dec 2021157
1 Jan 2020 – 31 Dec 2020106
1 Jan 2019 – 31 Dec 2019121
23 Apr 2018 – 31 Dec 2018126

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
BoardHanne Damgaard Jensen
BoardChristian Philip Hansen
BoardMads Hartvig Clausen
BoardJon Bondebjerg
BoardUlrik Spork
BoardAnker Gunvald Lundemose
BoardUlrik Spork
BoardHanne Damgaard Jensen
BoardRicki Boye
BoardMorten Amstrup Sandlykke
BoardHenrik Castenholm Fenger
Owner (10%)Sandlykke A/SCurrent
Owner (5%)HDJ & LEJ Invest ApSCurrent
Owner (50%)ROS Therapeutics Holding ApSCurrent
Owner (33%)ROS Therapeutics Holding ApS
Owner (5%)Rasmus Wilhelmsen
Owner (5%)INNOVATIONS A/S
Owner (5%)GreenOcean Capital ApS
Owner (10%)ROS Therapeutics ApS
Owner (67%)ROS Therapeutics Holding ApS
Owner (10%)SPORCON LIFESCIENCE ADVISORS ApS
Owner (100%)ROS Therapeutics Holding ApS
AuditorBDO Statsautoriseret RevisionspartnerselskabCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
AuditorBDO Holding VII, statsautoriseret revisionsaktieselskab
FounderROS Therapeutics Holding ApSCurrent

Address history (1 moves)

c/o Hanne Damgaard Jensen, Veddelev Engvej 6, 4000 Roskilde
Ole Maaløes Vej 3, 2200 København N

Employees per year

Number of employees at ROS Therapeutics ApS per year112018: 12018

Other companies at the same address

Similar companies in Roskilde

Questions and answers about ROS Therapeutics ApS

Has ROS Therapeutics ApS gone bankrupt?

No, ROS Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: in voluntary liquidation.

Who is the auditor of ROS Therapeutics ApS?

ROS Therapeutics ApS most recently used BDO Statsautoriseret Revisionspartnerselskab.

When was ROS Therapeutics ApS founded?

ROS Therapeutics ApS was founded on 23 April 2018.

What is the equity of ROS Therapeutics ApS?

Equity was DKK -8.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.